Is it known whether the active ingredients in Zerbaxa pass into human breast milk?

It is unknown whether Zerbaxa’s active ingredients, ceftolozane and tazobactam, pass into human milk; risk to newborns/infants cannot be excluded, and stopping breast-feeding or stopping/avoiding Zerbaxa must be decided by weighing breast-feeding benefits for the child against treatment benefits for the woman.